GLT8D1 Polyklonale Antilichaam, RBITC Vervoeging

GLT8D1 is a 371 amino acid single-pass type II transmembrane protein that is expressed by a gene residing on human chromosome 3. Chromosome 3 is made up of about 214 million bases encoding over 1,100 genes, including a chemokine receptor (CKR) gene cluster and a variety of human cancer-related gene loci. Key tumor suppressing genes on chromosome 3 include those that encode the apoptosis mediator RASSF1, the cell migration regulator HYAL1 and the angiogenesis suppressor SEMA3B. Marfan Syndrome, porphyria, von Hippel-Lindau syndrome, osteogenesis imperfecta and Charcot-Marie-Tooth Disease are a few of the numerous genetic diseases associated with chromosome 3. There are two isoforms of GLT8D1 that are produced as a result of alternative splicing events.

MGC94018; Da2 24; GALA4A; Glycosyltransferase 8 domain containing 1; Glycosyltransferase 8 domain-containing protein 1; Glycosyltransferase AD 017; MSTP139; GL8D1_HUMAN.

55830

Human, Mouse, Rat

201-300/371

GLT8D1

RBITC

KLH conjugated synthetic peptide derived from human GLT8D1

IF

Purified by Protein A.

570nm/595nm

1µg/µl

IF (IF=1:100-500)

Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.

Unmodified

Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.

55830